Green is an American medical geneticist, physician, and public health researcher.
He directs the Genomes2People Research Program in translational genomics and health outcomes in the Division of Genetics at Brigham and Women’s Hospital and Harvard Medical School.
Research led by Green includes clinical and research aspects of genomic medicine, including the development and disclosure of Alzheimer's disease risk estimates (the REVEAL Study) and one of the first prospective studies of direct-to-consumer genetic testing services (the PGen Study).
He is researching the implementation of medical sequencing in adults (the MedSeq Project) and newborns (the BabySeq Project).